Search results
Results from the WOW.Com Content Network
Hoosiers who qualify for a Medicaid program that reimburses for care provided at home will now have to apply through two new programs. Those 60 and older will apply to the Pathways for Aging Waiver.
Drug overdoses in Indiana have nearly doubled since 2010, growing from 923 to 1,809 in 2017. Approximately 4,000 Hoosiers have died from opioids in the last decade. Indiana’s drug-induced ...
The Substance Abuse and Mental Health Services Administration (SAMHSA; pronounced / ˈ s æ m s ə /) is a branch of the U.S. Department of Health and Human Services.SAMHSA is charged with improving the quality and availability of treatment and rehabilitative services in order to reduce illness, death, disability, and the cost to society resulting from substance abuse and mental illnesses.
Substance abuse, especially of alcohol and prescription drugs, for adults 60 and over is a fast-growing health problem in the U.S.. According to the 2022 National Survey on Drug Use and Health ...
In the United States, Medicaid is a government program that provides health insurance for adults and children with limited income and resources. The program is partially funded and primarily managed by state governments, which also have wide latitude in determining eligibility and benefits, but the federal government sets baseline standards for state Medicaid programs and provides a ...
Medicare coverage for dual-eligibles includes hospitalizations, physician services, prescription drugs, skilled nursing facility care, home health visits, and hospice care. Under Medicaid, states are required to cover certain items and services for dual-eligibles, including long-term nursing facility services and home health services.
The drug is an illegal Schedule I controlled substance in the United States, and the foreign facilities in which it is administered tend to have little oversight and range from motel rooms to one moderately-sized rehabilitation center.
The Drug Rebate Equalization Act of 2009 (DRE), introduced in the 111th United States Congress by Representative Bart Stupak as H.R. 904, and in the Senate by Senator Jeff Bingaman as S. 547, sought to equalize the treatment of prescription drug discounts between Medicaid managed care and Medicaid fee-for-service.